New drug combo targets tough cancers in early trial
NCT ID NCT04130542
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This early-phase study tested a new drug called LVGN6051, given alone or with the immunotherapy Keytruda, in 105 adults with advanced or spreading cancers. The main goal was to find safe doses and check for side effects. The study is complete, but results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030-3722, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Nebraska Cancer Specialist
Omaha, Nebraska, 68130, United States
-
The Johns Hopkins University
Baltimore, Maryland, 21205, United States
-
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94115, United States
-
University of California Irvine Health
Orange, California, 92868, United States
-
Verdi Oncology Research
Lafayette, Indiana, 47905, United States
Conditions
Explore the condition pages connected to this study.